On Monday 17 November, at 9 am in the Aula Magna of the Magna Graecia University of Catanzaro, in Germaneto, an important medical conference will take place organized by Francesca Mazza’s provider The title is: “Treatment of lung cancer in the early stages: state of the art and prospects in the era of interactivity”. The scientific managers are Marco Chiappetta and Vito Barbieri. While the president of the Scientific Committee is Francesco Givigliano.
“The treatment of lung cancer in the early stages represents a crucial challenge for the medical-scientific community. Especially in light of the continuous diagnostic and therapeutic innovations that are profoundly transforming the clinical approach”, we read in the rationale. The congress aims to offer an updated and multidisciplinary overview of this complex area, through a comparison between experts from different Italian and international hospitals and universities. The event will be divided into several thematic sessions that will address the main aspects of the pathology: from radiological and molecular diagnosis to surgical techniques, from personalized therapeutic strategies to the use of artificial intelligence and liquid biopsy. Particular attention will be paid to innovative surgical planning tools and options for inoperable patients, in line with the evolution of precision therapies.
The first part of the congress will explore the radiological implications of lung cancer and the fundamental role of advanced imaging technologies in the characterization of nodules. Following this, ample space will be given to modern diagnostics and new methodologies, including virtual bronchoscopic navigation and guided biopsy techniques. The afternoon sessions will be dedicated to the therapeutic approach, with insights into the initial and locally advanced stages of the disease, evaluating not only the surgical intervention but also the neoadjuvant and adjuvant systemic therapies, from an integrated and multidisciplinary perspective.
“The congress is aimed at specialists in pulmonology, thoracic and general surgery, radiotherapy oncology, nuclear medicine, pathological anatomy, radiology, general medicine and biology, presenting itself as a unique opportunity for professional updating and for direct discussion between clinicians, researchers and professionals in the sector”, the organizers say. Thanks to the presence of high-profile speakers and the variety of topics covered, the event aims to strengthen the culture of multidisciplinary collaboration and promote the adoption of the most effective diagnosis and treatment strategies, with the ultimate aim of improving the prognosis and quality of life of patients suffering from lung cancer.